KLK3 and prostate carcinoma: In the European Randomised Study of Screening for Prostate Cancer (ERSPC) and the Prostate, Lung, Colorectal and Ovarian Cancer Screening Trial (PLCO), the two largest prostate cancer screening trials, DRE and PSA were initially used as screening tests.